Adult solid tumours
Adult Solid Tumour testing
The Cancer Genetics laboratory at Guy’s Hospital forms part of the South East GLH.
The South East GLH currently provides all Solid Tumour tests aligned to the National Genomic Test Directory (NGTD) utilising two DNA panels and a 103-gene fusion RNA panel.
We are currently completing validation of a high-throughput, state of the art 500-gene panel, which will be available alongside existing DNA panels. This panel will be implemented in phases between December 2021 and February 2022; it includes additional targets which are likely to be of future prognostic and therapeutic importance.
If you are a new user of the SE GLH solid tumour service please could you contact us before submitting any samples to discuss the test order process and sample requirements.
Tests offered
The full list of tests offered can be found in the National Test Directory. This specifies which genomic tests are commissioned by the NHS in England, the technology by which they are available, and the patients who will be eligible to access a test.
SE GLH: Solid tumour test request forms
We prefer the request form to be completed electronically (PDF with live fields); if hand written, please ensure that all fields are completed and legible.
- confirming an identified somatic variant
- doing predictive testing for known familial variants
Sample type and requirements
The GLH can receive samples in the following formats:
- Curls/scrolls
- If the tumour cellularity of the whole section is >20% curls/scrolls of paraffin sections are acceptable. Please send in a sealed single-use microtube, either 1.5ml or 2ml. Ideally 5 sections of 10micron thickness should be submitted.
- Please do not send curls with an overall tumour cellularity of <20%; see section 2.
- Slides
- 5 sections of 10micron thickness on uncharged, unstained glass slides are required.
- The slides must be clearly labelled with the sample histology number and patient surname.
- An H&E section at 4micron should be submitted with the unstained sections – this can be diagnostic H&E or an additional slide cut at the same time as the unstained sections. This slide should be submitted with the USS and the request form.
- The area of the tumour must be outlined on the H&E section with a permanent marker pen; this will allow microdissection if necessary.
- The marked H&E slide and FFPE unstained slides must have the histology number and patient surname clearly marked on the slides and must correspond to that on the request form.
- Sections should be dried prior to transfer to the hub lab.
- Sections must NOT be baked onto slides.
- Please note that spare unstained slides sectioned previously should not be used for molecular analyses.
All slides or microtubes should be labelled with the laboratory histology number and patient surname. Unstained slides should be air-dried before packaging for dispatch. As RNA integrity from FFPE sections has been observed to decrease over time when exposed to light and air, air-dried sections intended for RNA analysis may benefit from storage in a fridge if not dispatched promptly.
Samples that are referred for MLH1 promoter hypermethlyation as part of the Lynch pathway require a matched normal control sample to run alongside the tumour sample; please send 5ml blood in EDTA. If it is not possible to obtain a blood sample from the patient, please send material from one normal tissue block in addition to the material from the tumour block as either curls or slides as described above.
The sample should be submitted together with the GLH request form fully completed, and a copy of the pathology report if authorised. The transport of the sample and documentation should be via either tracked Royal Mail or other recognised courier services. For more information about sample requirements please view the SEGLH Tissue Management SOP.
Laboratory criteria for rejecting samples
Full patient details must be provided, including full name, date of birth, surgical number of tissue block, along with details of primary tumour type (e.g. non-small cell lung cancer), subtype where applicable (e.g. adenocarcinoma) and simple type (e.g., liver biopsy / EBUS, lymph node).
Tissue blocks are not accepted, any blocks received will be returned untested.
Factors which affect performance of the test
The tissue must be appropriately fixed in 10% neutral-buffered formalin for no greater than 48h (due to the induction of formalin fixation artefacts). Microtomy of curls/slides must have been performed on microtome configured for molecular use by appropriately trained staff.
Turnaround times
10-14 days
Lab address and opening hours
Cancer Genetics
Genetics Laboratories
5th Floor Tower Wing
Guy’s Hospital
Great Maze Pond
London
SE1 9RT
Opening hours: 09:00-17:30
Results
If you would like your results to be discussed at the SE GLH Solid Tumour Genomic Tumour Advisory Board (GTAB) please send a completed referral form along with the results report to gst-tr.gtabsoutheastglh@nhs.net.
Key contacts
Nicola Foot, Service Lead – Nicola.Foot@viapath.co.uk
Amy Roe, Operations Lead
Gareth Gerrard, Scientific Lead – Gareth.Gerrard@gstt.nhs.uk
Tel: 020 7188 1716
Policy on personal information protection
To find out more on how we are using personal data to provide genomic testing please visit our privacy page.
GLH complaints policy
For complaints, please visit the Synnovis complaints page for the policy and procedure.